featured
Oral Simnotrelvir for the Treatment of Adults With Mild to Moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
N. Engl. J. Med 2024 Jan 18;390(3)230-241, B Cao, Y Wang, H Lu, C Huang, Y Yang, L Shang, Z Chen, R Jiang, Y Liu, L Lin, P Peng, F Wang, F Gong, H Hu, C Cheng, X Yao, X Ye, H Zhou, Y Shen, C Liu, C Wang, Z Yi, B Hu, J Xu, X Gu, J Shen, Y Xu, L Zhang, J Fan, R Tang, C WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.